Phase II multi-institutional prospective randomized trial comparing S-1 plus paclitaxel with paclitaxel alone as second-line chemotherapy in S-1 pretreated gastric cancer (CCOG0701)

被引：0
|
作者：
Koki Nakanishi
Daisuke Kobayashi
Yoshinari Mochizuki
Kiyoshi Ishigure
Seiji Ito
Hiroshi Kojima
Akiharu Ishiyama
Shinichi Fujitake
Toshio Shikano
Satoshi Morita
Yasuhiro Kodera
机构：
[1] Komaki City Hospital,Department of Surgery
[2] Nagoya University Graduate School of Medicine,Department of Gastroenterological Surgery
[3] Konan Kosei Hospital,Department of Surgery
[4] Aichi Cancer Center,Department of Gastroenterological Surgery
[5] Aichi Cancer Center Hospital,Department of Surgery
[6] Okazaki City Hospital,Department of Surgery
[7] Nishio Municipal Hospital,Department of Surgery
[8] Yokkaichi Municipal Hospital,Department of Surgery
[9] Kyoto University Graduate School of Medicine,Department of Biomedical Statistics and Bioinformatics
来源：
International Journal of Clinical Oncology | 2016年 / 21卷
关键词：
Gastric cancer; S-1; Paclitaxel; Second-line chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：557 / 565
页数：8
相关论文
共 50 条
  • [21] Assessing Potential Synergistic Effects of S-1 Plus Paclitaxel Chemotherapy in Gastric Cancer
    Kanellos, D.
    Kanellos, I.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (05) : 1442 - 1443
  • [22] Multicenter phase II study of weekly paclitaxel plus S-1 combination chemotherapy in patients with advanced gastric cancer
    Yuji Ueda
    Hisakazu Yamagishi
    Daisuke Ichikawa
    Kazuma Okamoto
    Eigo Otsuji
    Jun Morii
    Kinya Koizumi
    Naoki Kakihara
    Masataka Shimotsuma
    Tetsuro Yamashita
    Fumihiro Taniguchi
    Hideki Aragane
    Hiroshi Nishi
    Yoshiki Itokawa
    Satoshi Morita
    Junichi Sakamoto
    Gastric Cancer, 2010, 13 : 149 - 154
  • [23] Efficacy of S-1 in second-line chemotherapy after nab-paclitaxel plus gemcitabine for patients with advanced pancreatic cancer
    Iede, Kiyotsugu
    Yamada, Terumasa
    Kato, Ryo
    Ueda, Masami
    Tsuda, Yujiro
    Nakashima, Shinsuke
    Ohta, Katsuya
    Matsuyama, Jin
    Ikenaga, Masakazu
    Tominaga, Shusei
    CANCER REPORTS, 2020, 3 (02)
  • [24] Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial
    Ishigami, Hironori
    Fujiwara, Yoshiyuki
    Fukushima, Ryoji
    Nashimoto, Atsushi
    Yabusaki, Hiroshi
    Imano, Motohiro
    Imamoto, Haruhiko
    Kodera, Yasuhiro
    Uenosono, Yoshikazu
    Amagai, Kenji
    Kadowaki, Shigenori
    Miwa, Hiroto
    Yamaguchi, Hironori
    Yamaguchi, Takuhiro
    Miyaji, Tempei
    Kitayama, Joji
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (19) : 1922 - +
  • [25] Multicenter phase II study of weekly paclitaxel plus S-1 combination chemotherapy in patients with advanced gastric cancer
    Ueda, Yuji
    Yamagishi, Hisakazu
    Ichikawa, Daisuke
    Okamoto, Kazuma
    Otsuji, Eigo
    Morii, Jun
    Koizumi, Kinya
    Kakihara, Naoki
    Shimotsuma, Masataka
    Yamashita, Tetsuro
    Taniguchi, Fumihiro
    Aragane, Hideki
    Nishi, Hiroshi
    Itokawa, Yoshiki
    Morita, Satoshi
    Sakamoto, Junichi
    GASTRIC CANCER, 2010, 13 (03) : 149 - 154
  • [26] Phase III study of intraperitoneal paclitaxel plus s-1/paclitaxel compared with s-1/cisplatin in gastric cancer patients with peritoneal metastasis: PHOENIX-GC trial
    Ishigami, Hironori
    Fujiwara, Yoshiyuki
    Fukushima, Ryoji
    Nashimoto, Atsushi
    Yabusaki, Hiroshi
    Imamoto, Haruhiko
    Imano, Motohiro
    Kodera, Yasuhiro
    Uenosono, Yoshikazu
    Amagai, Kenji
    Kadowaki, Shigenori
    Miwa, Hiroto
    Yamaguchi, Takuhiro
    Yamaguchi, Hironori
    Watanabe, Toshiaki
    Kitayama, Joji
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [27] Randomized Phase II trial of paclitaxel plus valproic acid vs paclitaxel alone as second-line therapy for patients with advanced gastric cancer
    Fushida, Sachio
    Kaji, Masahide
    Oyama, Katsunobu
    Hirono, Yasuo
    Nezuka, Hideaki
    Takeda, Toshiya
    Tsukada, Tomoya
    Fujimoto, Daisuke
    Ohyama, Shigekazu
    Fujimura, Takashi
    Ohta, Tetsuo
    ONCOTARGETS AND THERAPY, 2015, 8 : 939 - 941
  • [28] Second-line chemotherapy with paclitaxel and doxifluridine after failure of S-1 in elderly patients with unresectable advanced or recurrent gastric cancer
    Yakabe, Tomomi
    Noshiro, Hirokazu
    Ikeda, Osamu
    Miyoshi, Atsushi
    Kitajima, Yoshihiko
    Satoh, Seiji
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (10) : 1499 - 1504
  • [29] Second-line chemotherapy with paclitaxel and doxifluridine after failure of S-1 in elderly patients with unresectable advanced or recurrent gastric cancer
    Tomomi Yakabe
    Hirokazu Noshiro
    Osamu Ikeda
    Atsushi Miyoshi
    Yoshihiko Kitajima
    Seiji Satoh
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 1499 - 1504
  • [30] Comparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trial
    Zhao, Xiaoying
    Chen, Zhiyu
    Zhang, Xiaowei
    Zhu, Xiaodong
    Zhang, Wen
    Qiu, Lixin
    Wang, Chenchen
    Huang, Mingzhu
    Zhang, Zhe
    Li, Wenhua
    Yang, Lei
    Guo, Weijian
    CANCER BIOLOGY & MEDICINE, 2023, 20 (09) : 682 - 688
12345